KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hims & Hers Health (HIMS) Cash from Financing Activities (2019 - 2025)

Historic Cash from Financing Activities for Hims & Hers Health (HIMS) over the last 7 years, with Q3 2025 value amounting to -$39.0 million.

  • Hims & Hers Health's Cash from Financing Activities fell 48.69% to -$39.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $813.5 million, marking a year-over-year increase of 92877.26%. This contributed to the annual value of -$107.8 million for FY2024, which is 83982.57% down from last year.
  • As of Q3 2025, Hims & Hers Health's Cash from Financing Activities stood at -$39.0 million, which was down 48.69% from $889.2 million recorded in Q2 2025.
  • In the past 5 years, Hims & Hers Health's Cash from Financing Activities registered a high of $889.2 million during Q2 2025, and its lowest value of -$39.0 million during Q3 2025.
  • In the last 5 years, Hims & Hers Health's Cash from Financing Activities had a median value of -$4.0 million in 2023 and averaged $47.9 million.
  • As far as peak fluctuations go, Hims & Hers Health's Cash from Financing Activities plummeted by 1330897.44% in 2022, and later skyrocketed by 364745.26% in 2025.
  • Hims & Hers Health's Cash from Financing Activities (Quarter) stood at -$78000.0 in 2021, then crashed by 13308.97% to -$10.5 million in 2022, then surged by 62.11% to -$4.0 million in 2023, then plummeted by 244.49% to -$13.7 million in 2024, then tumbled by 185.74% to -$39.0 million in 2025.
  • Its last three reported values are -$39.0 million in Q3 2025, $889.2 million for Q2 2025, and -$23.0 million during Q1 2025.